The Frost & Sullivan Digital Transformation Blog

A collection of expert insights and industry news to help you accelerate growth.

Featured

Lenovo’s Sphere Spectacular: A Grand Debut for Hybrid AI

Lenovo kicked off CES 2026 with a truly grand stage: the Las Vegas Sphere — a 366-foot-tall tech marvel with a four-football-field-wide wraparound screen and a 167,000-speaker sound system. The venue’s scale was not just dramatic; it mirrored Lenovo’s message that AI is becoming a platform layer that sits underneath everything. What made the...

Future-proofing Content Distribution and Infrastructure: 10 Imperatives Necessitating Next-gen Edge Architecture, AI Intelligence, Integrated Security, and Decentralized Delivery

A few years ago, content distribution was mostly about reach. If a video loaded and a page didn’t crash under traffic, the job was done. But today, that baseline no longer counts as success. Customers expect instant playback, real-time response, regional relevance, and absolute trust—whether they’re watching a live sports stream, accessing...

Sign Up

Sign up to get Frost & Sullivan’s best
and newest content delivered weekly to your inbox.

8 Ways to Maximize the Power of Foundational LLMs and Multimodal AI: Transforming Digital Content Services

This blog is based on the competitive analysis, Frost Radar™: Foundational LLMs and Multimodal GenAI Platforms, 2025 by Frost & Sullivan’s growth expert, Alaa Saayed, from the Digital Content Services team. In the race to stay relevant in an AI-first digital...

read more

BROWSE RECENT POSTS

The RNA Therapeutics Shift: From Experimental to Mainstream Growth

This blog is based on the detailed analysis, “Growth Opportunities in RNA Therapeutics,” conducted by Frost & Sullivan’s growth experts, Vandana Iyer and Priyanka Jain,  from TechVision Health & Wellness team. How RNA Therapeutics Are Redefining Modern...

The RNA Therapeutics Shift: From Experimental to Mainstream Growth

This blog is based on the detailed analysis, “Growth Opportunities in RNA Therapeutics,” conducted by Frost & Sullivan’s growth experts, Vandana Iyer and Priyanka Jain,  from TechVision Health & Wellness team. How RNA Therapeutics Are Redefining Modern...

The RNA Therapeutics Shift: From Experimental to Mainstream Growth

This blog is based on the detailed analysis, “Growth Opportunities in RNA Therapeutics,” conducted by Frost & Sullivan’s growth experts, Vandana Iyer and Priyanka Jain,  from TechVision Health & Wellness team. How RNA Therapeutics Are Redefining Modern...

Browse by Category

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.